| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.933 | 0.003 | 0.937 | Bronchodilator | 0.937 0.003 DBMET01386 | DBMET01386 | |
| 0.833 | 0.001 | 0.833 | Adrenaline agonist | 0.66 0.001 DBMET01386 | ||
| 0.796 | 0.005 | 0.803 | Toll-Like receptor 7 agonist | 0.803 0.005 DBMET01386 | DBMET01386 | |
| 0.794 | 0.005 | 0.8 | Toll-Like receptor agonist | 0.8 0.005 DBMET01386 | DBMET01386 | |
| 0.769 | 0.001 | 0.769 | Beta 1 adrenoreceptor agonist | 0.391 0.001 DBMET01386 | ||
| 0.749 | 0.001 | 0.749 | Beta adrenoreceptor agonist | 0.521 0.001 DBMET01386 | ||
| 0.733 | 0.001 | 0.733 | Beta adrenoreceptor antagonist | 0.428 0.002 DBMET01386 | ||
| 0.687 | 0.007 | 0.687 | Vasodilator, peripheral | 0.492 0.029 DBMET01386 | ||
| 0.664 | 0.005 | 0.678 | Antiadrenergic | 0.678 0.004 DBMET01386 | DBMET01386 | |
| 0.664 | 0.005 | 0.677 | Adrenaline antagonist | 0.677 0.004 DBMET01386 | DBMET01386 | |
| 0.656 | 0.009 | 0.656 | Spasmolytic | 0.528 0.02 DBMET01386 | ||
| 0.579 | 0.008 | 0.591 | Calcium channel L-type activator | 0.591 0.007 DBMET01386 | DBMET01386 | |
| 0.561 | 0.001 | 0.561 | Beta 2 adrenoreceptor agonist | 0.354 0.001 DBMET01386 | ||
| 0.546 | 0.002 | 0.546 | Beta 2 adrenoreceptor antagonist | 0.45 0.002 DBMET01386 | ||
| 0.55 | 0.01 | 0.55 | Vasodilator, coronary | 0.421 0.029 DBMET01386 | ||
| 0.402 | 0.002 | 0.452 | Calcium-sensing receptor antagonist | 0.452 0.001 DBMET01386 | DBMET01386 | |
| 0.447 | 0.05 | 0.573 | Antiobesity | 0.573 0.024 DBMET01386 | DBMET01386 | |
| 0.395 | 0.002 | 0.395 | Beta 1 adrenoreceptor antagonist | 0.261 0.003 DBMET01386 | ||
| 0.421 | 0.08 | 0.479 | Cyclophilin D inhibitor | 0.479 0.057 DBMET01386 | DBMET01386 | |
| 0.356 | 0.03 | 0.356 | Psychostimulant | 0.332 0.035 DBMET01386 | ||
| 0.35 | 0.033 | 0.35 | Vasodilator | 0.283 0.054 DBMET01386 | ||
| 0.305 | 0.004 | 0.305 | Acetylcholine M3 receptor antagonist | 0.227 0.005 DBMET01386 | ||
| 0.334 | 0.044 | 0.334 | Cardiotonic | 0.268 0.071 DBMET01386 | ||
| 0.271 | 0.012 | 0.271 | Acetylcholine muscarinic antagonist | 0.232 0.018 DBMET01386 | ||
| 0.256 | 0.02 | 0.256 | Cholinergic antagonist | 0.229 0.025 DBMET01386 | ||
| 0.255 | 0.019 | 0.255 | Acetylcholine antagonist | 0.228 0.024 DBMET01386 | ||
| 0.238 | 0.004 | 0.271 | Beta 3 adrenoreceptor antagonist | 0.271 0.003 DBMET01386 | DBMET01386 | |
| 0.197 | 0.009 | 0.197 | Alpha adrenoreceptor agonist | 0.134 0.019 DBMET01386 | ||
| 0.231 | 0.048 | 0.231 | Nitric-oxide synthase stimulant | 0.201 0.088 DBMET01386 | ||
| 0.247 | 0.071 | 0.281 | Tyrosine 3 hydroxylase inhibitor | 0.281 0.044 DBMET01386 | DBMET01386 | |
| 0.181 | 0.03 | 0.181 | Alpha adrenoreceptor antagonist | 0.089 0.064 DBMET01386 | ||
| 0.264 | 0.114 | 0.264 | Sodium/bile acid cotransporter inhibitor | 0.26 0.118 DBMET01386 | ||
| 0.218 | 0.078 | 0.24 | Peptidyltransferase inhibitor | 0.24 0.058 DBMET01386 | DBMET01386 | |
| 0.257 | 0.139 | 0.257 | Calcium channel activator | |||
| 0.113 | 0.003 | 0.113 | Beta 3 adrenoreceptor agonist | 0.109 0.003 DBMET01386 | ||
| 0.211 | 0.103 | 0.211 | Hypoglycemic | 0.182 0.132 DBMET01386 | ||
| 0.158 | 0.051 | 0.175 | Adenylate cyclase stimulant | 0.175 0.03 DBMET01386 | DBMET01386 | |
| 0.113 | 0.007 | 0.113 | Mineralocorticoid receptor antagonist | |||
| 0.212 | 0.109 | 0.23 | Interleukin agonist | 0.23 0.094 DBMET01386 | DBMET01386 | |
| 0.184 | 0.111 | 0.184 | Free radical scavenger | 0.175 0.119 DBMET01386 | ||
| 0.181 | 0.111 | 0.181 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.187 | 0.125 | 0.192 | Antioxidant | 0.192 0.121 DBMET01386 | DBMET01386 | |
| 0.113 | 0.057 | 0.113 | Electron transport complex I inhibitor | 0.097 0.09 DBMET01386 | ||
| 0.113 | 0.061 | 0.113 | Mucolytic | 0.104 0.072 DBMET01386 | ||
| 0.074 | 0.028 | 0.074 | Alpha 2 adrenoreceptor agonist | 0.059 0.044 DBMET01386 | ||
| 0.211 | 0.171 | 0.213 | Interleukin 2 agonist | 0.213 0.168 DBMET01386 | DBMET01386 | |
| 0.057 | 0.023 | 0.057 | Dopamine D2 agonist | |||
| 0.086 | 0.055 | 0.086 | Acetylcholine M3 receptor agonist | 0.081 0.059 DBMET01386 | ||
| 0.088 | 0.057 | 0.088 | Alpha 2 adrenoreceptor antagonist | |||
| 0.155 | 0.126 | 0.155 | HERG channel blocker | |||
| 0.131 | 0.106 | 0.131 | Growth hormone agonist | 0.131 0.106 DBMET01386 | ||
| 0.074 | 0.057 | 0.076 | Keratolytic | 0.076 0.054 DBMET01386 | DBMET01386 | |
| 0.093 | 0.078 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.039 DBMET01386 | DBMET01386 | |
| 0.091 | 0.08 | 0.091 | Expectorant | |||
| 0.063 | 0.054 | 0.184 | Phenylalanine 4-hydroxylase inhibitor | 0.184 0.008 DBMET01386 | DBMET01386 | |
| 0.025 | 0.02 | 0.025 | Sodium/glucose cotransporter inhibitor | |||
| 0.034 | 0.03 | 0.038 | Bombesin 1 receptor antagonist | 0.038 0.024 DBMET01386 | DBMET01386 | |
| 0.185 | 0.184 | 0.185 | Transcription factor NF kappa B inhibitor | |||
| 0.097 | 0.106 | 0.118 | Estrogen antagonist | 0.118 0.058 DBMET01386 | DBMET01386 | |
| 0.085 | 0.101 | 0.115 | Anesthetic local | 0.115 0.071 DBMET01386 | DBMET01386 | |
| 0.074 | 0.091 | 0.081 | Aminoacyl-tRNA synthetase inhibitor | 0.081 0.075 DBMET01386 | DBMET01386 | |
| 0.17 | 0.191 | 0.23 | Hypoxia-inducible factor 1 alpha inhibitor | 0.23 0.119 DBMET01386 | DBMET01386 | |
| 0.221 | 0.272 | 0.246 | 5 Hydroxytryptamine release inhibitor | 0.246 0.234 DBMET01386 | DBMET01386 | |
| 0.044 | 0.107 | 0.076 | Glutamate decarboxylase inhibitor | 0.076 0.048 DBMET01386 | DBMET01386 | |
| 0.067 | 0.131 | 0.095 | Anabolic | 0.095 0.07 DBMET01386 | DBMET01386 | |
| 0.071 | 0.137 | 0.097 | M18 aspartyl aminopeptidase inhibitor | 0.097 0.096 DBMET01386 | DBMET01386 | |
| 0.099 | 0.206 | 0.166 | Insulin sensitizer | 0.166 0.113 DBMET01386 | DBMET01386 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |